Mitsutoshi Kurosawa

Clinicopathologic analysis of <scp>TAFRO</scp> syndrome demonstrates a distinct subtype of <scp>HHV</scp>‐8‐negative multicentric Castleman disease

Noriko Iwaki, David C. Fajgenbaum, Christopher S. Nabel et al. · American Journal of Hematology · 2015 · 273 citations · Full text

Immunodeficiencies, Immunology, Pathology +20

Familial Essential Thrombocythemia Associated With One-Base Deletion in the 5′-Untranslated Region of theThrombopoietin Gene

Takeshi Kondo, M Okabe, Masayoshi Sanada et al. · Blood · 1998 · 169 citations

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 132 citations

Hematological Malignancy, Frontline Bortezomib, Lymphoid Neoplasia +13

Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

Mitsutoshi Kurosawa, Masakatsu Yonezumi, Satoshi Hashino et al. · International Journal of Hematology · 2012 · 125 citations

Treatment Outcome, Antifungal Agent, Antifungal Agents +5

Point mutation of K-ras gene codon 12 in biliary tract tumors

Masao Watanabe, Masahiro Asaka, Junji Tanaka et al. · Gastroenterology · 1994 · 121 citations

Tumor Biology, Somatic Variant, Biliary Cancer +8